A Reappraisal of Ciprofloxacin Use in Infants and Children

Marcia L. Buck, PharmD, FCCP, FPPAG, BCPPS

Disclosures

Pediatr Pharm. 2018;24(8) 

In This Article

Summary

The use of ciprofloxacin in infants and children requires careful consideration. While still a very useful option for patients with multidrug resistant infections susceptible to a fluoroquinolone, it should no longer be considered first-line therapy for uncomplicated infections. Growing concerns over bacterial resistance and the risk for serious, sometimes irreversible adverse effects, now limit its use to only those patients with no safer alternatives.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....